Mark Lazenby on the Screening for Psychosocial Distress Program

Article

Mark Lazenby, PhD, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses the Screening for Psychosocial Distress Program, which was launched in 2014 by APOS in partnership with Yale School of Nursing.

Mark Lazenby, PhD, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses the Screening for Psychosocial Distress Program, which was launched in 2014 by APOS in partnership with Yale School of Nursing.

Two cancer care professionals, ideally from different disciplines, are trained over two years to implement comprehensive distress screening, evaluate that screening, refer the patient to additional resources if needed and properly document the results.

The participants attend two APOS conferences and learn how to implement live in workshops. Interested cancer care professionals can apply online at http://www.apos-society.org.

Related Videos
Testi
Patrick Buxton, RN, BSN
Cheryl VerStrate on the Pitfalls of Direct-to-Consumer Genetic Tests
Elizabeth Aronson
MPN-Associated Anemia: What Nurses Should Look Out For
Cancer-Related Cognitive Impairment
Charina Toste
Lindsey Lyle
Related Content
lung cancer

Experts Make the Case for More Inclusive Lung Cancer Screening Guidelines

December 6th 2023
Article

A smoking-duration cutoff may be a better measure for determining lung cancer screening eligibility compared with smoking pack-years.

The Vitals

Nicole Gay Shares How She Counsels Patients on Lung Cancer Screenings

November 15th 2023
Podcast

Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.

lung cancer

Stress May Inhibit Immunotherapy’s Efficacy in Treating Cancer

November 28th 2023
Article

Finding ways to prevent and manage stress may be key to optimizing clinical outcomes in oncology.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

October 2nd 2023
Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

electric patient reported outcomes

PRO-TECT Trial Shows That ePROs May Be Feasibly Implemented Into Routine Oncology Practice

November 27th 2023
Article

Electronic patient-reported outcomes may have a place in high-quality cancer care, according to investigators.

Liquid Biopsy Analysis

LINE-1-ORF1p Is a Promising Biomarker for Early Cancer Detection, But More Research Is Needed

November 22nd 2023
Article

Oncology nurses can help patients understand the potential benefit of ORF1p testing for early cancer detection and its current limitations.

© 2023 MJH Life Sciences

All rights reserved.